1. Home
  2. ANL vs APT Comparison

ANL vs APT Comparison

Compare ANL & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANL
  • APT
  • Stock Information
  • Founded
  • ANL 2004
  • APT 1983
  • Country
  • ANL Cayman Islands
  • APT Canada
  • Employees
  • ANL N/A
  • APT N/A
  • Industry
  • ANL
  • APT
  • Sector
  • ANL
  • APT
  • Exchange
  • ANL Nasdaq
  • APT Nasdaq
  • Market Cap
  • ANL 73.8M
  • APT 61.6M
  • IPO Year
  • ANL 2023
  • APT 1995
  • Fundamental
  • Price
  • ANL $1.82
  • APT $4.72
  • Analyst Decision
  • ANL Strong Buy
  • APT
  • Analyst Count
  • ANL 2
  • APT 0
  • Target Price
  • ANL $9.00
  • APT N/A
  • AVG Volume (30 Days)
  • ANL 10.1K
  • APT 27.6K
  • Earning Date
  • ANL 06-10-2025
  • APT 05-08-2025
  • Dividend Yield
  • ANL N/A
  • APT N/A
  • EPS Growth
  • ANL N/A
  • APT 2.28
  • EPS
  • ANL N/A
  • APT 0.36
  • Revenue
  • ANL N/A
  • APT $58,180,000.00
  • Revenue This Year
  • ANL N/A
  • APT N/A
  • Revenue Next Year
  • ANL N/A
  • APT N/A
  • P/E Ratio
  • ANL N/A
  • APT $13.09
  • Revenue Growth
  • ANL N/A
  • APT N/A
  • 52 Week Low
  • ANL $1.10
  • APT $4.06
  • 52 Week High
  • ANL $8.88
  • APT $6.44
  • Technical
  • Relative Strength Index (RSI)
  • ANL 45.00
  • APT 59.84
  • Support Level
  • ANL $1.71
  • APT $4.25
  • Resistance Level
  • ANL $2.10
  • APT $4.79
  • Average True Range (ATR)
  • ANL 0.09
  • APT 0.18
  • MACD
  • ANL 0.01
  • APT 0.03
  • Stochastic Oscillator
  • ANL 28.21
  • APT 87.04

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.

Share on Social Networks: